Continuous Manufacturing– tag –
-
Upstream Process Optimization Drives Biologics Production Efficiency Towards Continuous and Perfusion Systems
World Pharma Today Unknown Overview Optimizing upstream processes is critical for enhancing biologics production efficiency, with a strong focus on cell culture media design, feed strategies, and bioreactor control. Chemically defined, s... -
Transcenta Therapeutics and WuXi Biologics Forge Strategic Alliance to Expedite Commercialization of HiCB Continuous Bioprocessing Technologies
BioSpace USA Overview Transcenta Therapeutics and WuXi Biologics have entered a strategic collaboration to accelerate the commercialization and deployment of Transcenta's proprietary High-Intensity Continuous Bioprocessing (HiCB) platfor... -
Perfusion Bioreactor Adoption Doubles to 65.8% Since 2016, Accelerating Shift to Continuous Biomanufacturing
synbio.intel USA Overview A BioPlan Associates survey from August 2026 reveals that single-use perfusion equipment usage has doubled to 65.8% across all production stages since 2016, indicating an accelerating shift towards continuous bi... -
Real-Time Bioreactor Monitoring Advances with Raman Spectroscopy, Enhancing Cell Culture Precision and Efficiency
Spectroscopy Online USA Overview Process Raman Spectroscopy, utilizing fiber-optic probes, enables real-time, in-line chemical monitoring in bioreactors, tracking reaction conversion and cell-culture metabolite concentrations without sam... -
Biopharma’s Evolving Blueprint: AGC Biologics Expands Global Capacity, Enzene Drives Continuous Manufacturing Adoption
Pharma Manufacturing USA Overview This news digest highlights several pivotal developments in the biopharmaceutical manufacturing sector, showcasing an industry-wide acceleration towards enhanced capacity and technological innovation. Ke... -
Enzene Unveils ‘NeX’ Partnership Model to Globalize Biologics Production via Continuous Manufacturing
PharmaSource India Overview Enzene has launched 'NeX,' an end-to-end partnership model designed to establish regional biopharmaceutical manufacturing capabilities globally. Leveraging its fully connected continuous manufacturing platform... -
Sartorius Drives Bioprocessing Evolution: New Ambr 250 HT and Pionic Modules Fast-Track Cell Therapies and Continuous Manufacturing
Sartorius boerse.de Investing.com Germany Overview Sartorius reported strong H1 2026 growth, largely fueled by new innovations in its Bioprocess Solutions Division. Key launches include the Ambr 250 HT Cell Therapies Vessel, designed for... -
Continuous Bioprocessing Delivers Significant Gains in Biopharmaceutical Manufacturing Efficiency and Cost Reduction, Driven by 500L Single-Use Perfusion Bioreactors
BioProcess International USA Overview Biopharmaceutical manufacturers are rapidly adopting continuous bioprocessing, integrating upstream cell culture and downstream operations to boost productivity, cut costs, and reduce facility footpr... -
APAC’s Bioprocessing Technology Ready, Regulatory Certainty Needed for Continuous Manufacturing Investment; China/Korea CDMOs Lead Adoption
BioProcess International USA Overview A BioProcess International article analyzes regulatory challenges for continuous and intensified bioprocessing adoption in the Asia Pacific (APAC) region. While hardware and software for perfusion bi... -
Continuous Chromatography & ICH Q13 Overcome Downstream Purification Challenges Amplified by Upstream Intensification
Separation Science Global Overview According to Separation Science, upstream bioreactor intensification, including N-1 perfusion seeding and high-density fed-batch, is creating new challenges for downstream purification. Continuous purif...
12